|Mr. Robert R. Galvin||Interim CEO & COO||925k||N/A||1961|
|Mr. Julius John Kalcevich||CFO & Corp. Sec.||950k||N/A||1975|
|Mr. Randy Maslow||Co-Founder & Consultant||975k||N/A||1955|
|Ms. Megan W. Kulick CFA||VP of Investor Relations||N/A||N/A||N/A|
|Mr. Andrew R. Ryan Esq.||Gen. Counsel||N/A||N/A||N/A|
|Mr. Michael R. Woolston||Sr. VP of Manufacturing, Supply Chain & Quality||N/A||N/A||N/A|
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.
iAnthus Capital Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.